CHICAGO and FORT WORTH, Texas, May 28, 2024 (GLOBE NEWSWIRE) -- Actuate Therapeutics, Inc. ("Actuate") announced today that it has filed a registration statement with the Securities and Exchange Commission for a proposed initial public offering of its common stock. The number of shares to be offered and the price range for the offering have not yet been determined. The proposed offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering. Actuate intends to list its common stock on the Nasdaq Capital Market under the symbol "ACTU". Titan Partners Group, a ...